Despite the clinical reports, few studies have focused on reducing the
cardiotoxicity of
cisplatin. In the present study,
cardiotoxicity was examined after a single ip injection of
cisplatin (7mg/kg) in rats.
Apocynin was given in
drinking water (600mg/L) for five successive days before and after
cisplatin injection. At the end of the experiment, hemodynamic parameters were recorded, animals were sacrificed and serum
creatine kinase-MB activity was determined. The whole ventricle was isolated for estimation of
tumor necrosis factor-alpha (TNF-α) content,
NADPH oxidase,
myeloperoxidase and
caspase-3 activities in addition to nuclear factor erythroid 2-related factor 2 (Nrf2),
heme oxygenase-1 (HO-1) and
nuclear factor kappa B (NF-κB) gene expressions. Furthermore, oxidative stress markers and
antioxidant enzymes were measured in postmitochondrial and mitochondrial fractions. Mitochondrial membrane potential, nuclear DNA fragmentation and cardiomyocyte cross-sectional area were also evaluated.
Apocynin was effective against
cisplatin-induced decrement in heart rate and blood pressure. Moreover, pretreatment with
apocynin notably ameliorated the state of oxidative stress, mitigated
inflammation and preserved mitochondrial membrane potential.
Apocynin provided also a significant cardioprotection as revealed by alleviating the overexpression of Nrf2, HO-1 and NF-κB, the elevation of
caspase-3 activity, the prominent nuclear DNA fragmentation and the decreased cardiomyocyte cross-sectional area. This study highlights the potential role of
apocynin in inhibiting
cisplatin-induced hemodynamic changes, postmitochondrial and mitochondrial damage as indicated by improvement in the state of oxidative stress,
inflammation and apoptosis.